http://www.onemedplace.com/blog/wp-content/uploads/2009/05/pillsmoney.jpg
Pharmaceutical company MediciNova announced that it will buy Avigen (AVGN) for $1.24 per share, approximately $37 million.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/08/knees.jpg
We've heard of drugs underperforming in clinical trials, but is it possible for a drug to over-perform?
View Article
More Pages to Explore .....
